Japan Cell Therapy Hopes Hit By HeartSheet Full Approval Hurdles

 
• By Lisa Takagi

Despite initial promise, a novel autologous cell transplant therapy for severe heart failure has faced multiple challenges in gaining full approval in Japan, potentially providing learnings for other developers of regenerative medicines.

HeartSheet was heart to provide a new treatment option for severe heart failure to avoid heart transplant.
HeartSheet a new option for severe heart failure in Japan but challenges abounded • Source: Shutterstock

More from Japan

More from Focus On Asia